Lataa...

Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells

There is insufficient information about combination therapy with approved anti-influenza agents. We tested combinations that paired a neuraminidase (NA) inhibitor (zanamivir, oseltamivir carboxylate, or peramivir) with rimantadine against infection of MDCK cells with H1N1 and H3N2 subtypes of influe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Govorkova, Elena A., Fang, Hong-Bin, Tan, Ming, Webster, Robert G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2004
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC529183/
https://ncbi.nlm.nih.gov/pubmed/15561867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.12.4855-4863.2004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!